๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Symptom monitoring for relapse prevention in schizophrenia

โœ Scribed by Frederica W. O'Connor


Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
984 KB
Volume
5
Category
Article
ISSN
1532-8228

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Relapse prevention in patients with schi
โœ B. van Meijel; M. van der Gaag; R.S. Kahn; M.H.F. Grypdonck ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 144 KB

This article describes the development and content of a nursing intervention protocol for the recognition of the early signs of psychosis. Applying this protocol, nurses can contribute to the prevention of psychotic relapse in patients with schizophrenia or a related disorder. The background and con

Symptom monitoring in schizophrenia: Pot
โœ Edna K. Hamera; Kathryn A. Peterson; Leslie M. Young; Mardee McNary Schaumloffel ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 787 KB

In this study a symptom self-regulation model was used as a framework to examine the characteristics and stability of indicators of illness identified by individuals with schizophrenia. Subjects were interviewed to determine if they could identify indicators of illness and describe characteristics o

Towards consensus in the long-term manag
โœ M. Taylor; I. Chaudhry; M. Cross; E. McDonald; P. Miller; L. Pilowsky; P. Strick ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB

Approach to developing guidance When developing guidance for the long-term management of schizophrenia, one approach is to adopt a proactive strategy that sets out clear treatment goals and strategies. This should involve a broad view being taken, embracing overall mental and physical well-being rat

New psychotherapeutic approaches to resi
โœ Chiara Rafanelli; Seung K. Park; Giovanni A. Fava ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 2 views

Relapse and recurrence are vexing problems of unipolar depression. Awareness of their frequent occurrence has led to the development of pharmacological long-term strategies. A substantial proportion of patients with mood disorders still display residual symptoms upon successful treatment of their il